Melatonin Ameliorates Corticosterone-Mediated Oxidative Stress-Induced Colitis in Sleep-Deprived Mice Involving Gut Microbiota
Overview
Endocrinology
Authors
Affiliations
Background: Inflammatory bowel disease (IBD) is a result of a complex interplay, making development of a specific treatment a challenging task. Corticosterone was considered a risk factor of stress relative enteritis. Our previous studies found that melatonin exerts an improvement effect in sleep deprivation (SD)- induced corticosterone overproduction and colitis. A present study further explored the mechanism whereby melatonin prevented corticosterone-mediated SD-induced colitis.
Methods: A 72-hour SD mouse model with or without melatonin supplementation and fecal microbiota transplantation (FMT) to investigate the core role of corticosterone in melatonin-mediated gut microbiota improving SD-induced colitis. Further, corticosterone-treated mice were assessed to the effect of melatonin on corticosterone-mediated gut microbiota dysbiosis-induced colitis. Meanwhile, an in vitro test studied modulatory mechanism of metabolite melatonin.
Results: SD caused an excessive corticosterone, gut microbiota disorder and colitis phenotype. Similarly, corticosterone-supplemented mice also exhibited gut microbiota dysbiosis and colitis, and the FMT from SD-mice to normal mice could restore the SD-like colitis, but no change in the corticosterone level, which suggested that corticosterone-mediated intestinal microbiota imbalance plays a central role in SD-induced colitis. Further, we demonstrated melatonin-mediated MT2 weakened GR feedback, suppressed oxidative stress, restored the intestinal microbiota and its metabolites homeostasis, and inactivated the STAT3/AP-1/NF-B pathway-induced inflammatory response in vivo and in vitro.
Conclusions: We revealed that excessive corticosterone is a core risk factor for SD-induced colitis and provided a better understanding of the effects of melatonin, expected to be a personalized targeted therapy drug, on corticosterone-mediated gut microbiota inducing colitis.
Shirokova O, Kuzmina D, Zaborskaya O, Shchelchkova N, Kozliaeva E, Korotchenko S Int J Mol Sci. 2025; 26(3).
PMID: 39941015 PMC: 11818548. DOI: 10.3390/ijms26031251.
Afzal A Front Physiol. 2024; 15:1501334.
PMID: 39703668 PMC: 11655511. DOI: 10.3389/fphys.2024.1501334.
Gut Microbiome Interactions with Oxidative Stress: Mechanisms and Consequences for Health.
Semenova N, Garashchenko N, Kolesnikov S, Darenskaya M, Kolesnikova L Pathophysiology. 2024; 31(3):309-330.
PMID: 39051221 PMC: 11270257. DOI: 10.3390/pathophysiology31030023.
Jurjus A, El Masri J, Ghazi M, El Ayoubi L, Soueid L, Gerges Geagea A Nutrients. 2024; 16(8).
PMID: 38674926 PMC: 11054672. DOI: 10.3390/nu16081236.
Jiang L, Ye Y, Han Y, Wang Q, Lu H, Li J Cell Discov. 2024; 10(1):35.
PMID: 38548771 PMC: 10978833. DOI: 10.1038/s41421-024-00665-0.